Inventor · disambiguated record
Kathleen Ann Elias
Also filed as: ELIAS KATHLEEN A · ELIAS KATHLEEN ANN
20 granted patents·9 pending applications·299 citations·filing 1994–2024
96Inventor score
Files withTAKEDA PHARMACEUTICALS CO9CYTOKINETICS INC7GENENTECH INC4CYTOKINETICS INC A DELAWARE CO2TAKEDA PHARMACEUTICAL2
Top patents by PatentIndex Score
29 records- 0198US8362211B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2011·Granted Jan 29, 2013·71 cites·12 claims
- 0297US11414496B2Anti-CD38 binding domainsMILLENNIUM PHARM INC·Filed 2020·Granted Aug 16, 2022·4 cites·21 claims
- 0395US9676869B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 13, 2017·12 cites·20 claims
- 0495US5798337ALow molecular weight peptidomimetic growth hormone secretagoguesGENENTECH INC·Filed 1994·Granted Aug 25, 1998·70 cites·26 claims
- 0594US10494444B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 3, 2019·8 cites·10 claims
- 0694US10336833B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jul 2, 2019·9 cites·30 claims
- 0793US7399866B2Compounds, compositions, and methodsCYTOKINETICS INC·Filed 2004·Granted Jul 15, 2008·29 cites·8 claims
- 0893US2025171561A1Anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0992US8926969B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Jan 6, 2015·14 cites·17 claims
- 1092US7491826B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2004·Granted Feb 17, 2009·27 cites·8 claims
- 1190US9790285B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 17, 2017·7 cites·24 claims
- 1290US9102744B2Conjugated anti-CD38 antibodiesELIAS KATHLEEN ANN·Filed 2011·Granted Aug 11, 2015·13 cites·17 claims
- 1388US6599694B2Method of characterizing potential therapeutics by determining cell-cell interactionsCYTOKINETICS INC·Filed 2000·Granted Jul 29, 2003·13 cites·15 claims
- 1485US12209138B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jan 28, 2025·0 cites·17 claims
- 1584US7053094B2Compositions and methods for treating heart failureCYTOKINETICS INC·Filed 2005·Granted May 30, 2006·3 cites·15 claims
- 1678US11434304B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 6, 2022·0 cites·28 claims
- 1776US12312411B2Anti-CD38 binding domainsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted May 27, 2025·0 cites·20 claims
- 1873US7094869B2Low molecular weight peptidomimetic growth hormone secretagoguesGENENTECH INC·Filed 2002·Granted Aug 22, 2006·4 cites·4 claims
- 1972US2020031951A1Conjugated anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 2070US6908923B2Compositions and methods for treating heart failureCYTOKINETICS INC·Filed 2002·Granted Jun 21, 2005·3 cites·43 claims
- 2167US2009176307A1Compounds, Compositions and MethodsCYTOKINETICS INC·Filed 2009·Application pending·0 cites
- 2263US2002119441A1Method of characterizing potential therapeutics by determining cell-cell interactionsCYTOKINETICS INC A DELAWARE CO·Filed 2002·Application pending·0 cites
- 2361US2005208471A1Method of characterizing potential therapeutics by determining cell-cell interactionsCYTOKINETICS INC A DELAWARE CO·Filed 2005·Application pending·0 cites
- 2458US7605164B2Compositions and methods for treating heart failureCYTOKINETICS INC·Filed 2006·Granted Oct 20, 2009·0 cites·15 claims
- 2558US2006063807A1Low molecular weight peptidomimetic growth hormone secretagoguesGENENTECH INC·Filed 2005·Application pending·0 cites
- 2652US6034216ALow molecular weight peptidomimetic growth hormone secretagoguesGENENTECH INC·Filed 1998·Granted Mar 7, 2000·12 cites·7 claims
- 2741US2021213006A1Methods of treating neurodegenerative diseasesSEAL ROCK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2841US2003158186A1Compositions and methods for treating heart failureFiled 2002·Application pending·0 cites
- 2933US2002111461A1Low molecular weight peptidomimetic growth hormone secretagoguesFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathleen Ann Elias files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →